Biogen
Healthcare & Life Sci
Company overview
Biogen develops medicines for hard-to-treat diseases. Its major drugs include Tecfidera, Avonex, Plegridy, and Tysabri for multiple sclerosis, Spinraza for spinal muscular atrophy, and Skyclarys for Friedreich's ataxia.
Biogen was founded in 1978 in Geneva. It's a public company traded on NASDAQ under the ticker BIIB. In 2025 it reported $9.89 billion in revenue and had 7,500 employees. Historically, the median salary is ~$223,500. Biogen is a top-tier H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Cambridge, United States